Have a personal or library account? Click to login
The role of unenhanced phase of the liver in the scanning protocol of metastatic breast cancer: implications for sensitivity, response evaluation and size measurement Cover

The role of unenhanced phase of the liver in the scanning protocol of metastatic breast cancer: implications for sensitivity, response evaluation and size measurement

Open Access
|Nov 2021

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. doi: 10.3322/caac.21492
  2. Chikarmane SA, Tirumani SH, Howard SA, Jagannathan JP, DiPiro P. Metastatic patterns of breast cancer subtypes: what radiologists should know in the era of personalized cancer medicine. Clin Radiol 2015; 70: 1-10. doi: 10.1016/j.crad.2014.08.015
  3. Zimmerman P, Lu DS, Yang LY, Chen S, Sayre J, Kadell B. Hepatic metastases from breast carcinoma: comparison of noncontrast, arterial-dominant, and portal-dominant phase spiral CT. J Comput Assist Tomogr 2000; 24: 197-203. doi: 10.1097/00004728-200003000-00003
  4. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000; 174: 691-8. doi: 10.2214/ajr.174.3.1740691
  5. Francis IR, Cohan RH, McNulty NJ, Platt JF, Korobkin M, Gebremariam A, et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol 2003; 180: 1217-24. doi: 10.2214/ajr.180.5.1801217
  6. Soyer P, Poccard M, Boudiaf M, Abitbol M, HamziL, Panis Y, et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 2004; 231: 413-20. doi: 10.1148/radiol.2312021639
  7. DuBrow RA, David CL, Libshitz HI, Lorigan JG. Detection of hepatic metastases in breast cancer: the role of nonenhanced and enhanced CT scanning. J Comput Assist Tomogr 1990; 14: 366-9. doi: 10.1097/00004728199005000-00008
  8. Patten RM, Byun JY, Freeny PC. CT of hypervascular hepatic tumors: are unenhanced scans necessary for diagnosis? AJR Am J Roentgenol 1993; 161: 979-84. doi: 10.2214/ajr.161.5.8273641
  9. O’Malley ME, Halpern E, Mueller PR, Gazelle GS. Helical CT protocols for the abdomen and pelvis: a survey. AJR Am J Roentgenol 2000; 175: 109-13. doi: 10.2214/ajr.175.1.1750109
  10. Frederick MG, Paulson EK, Nelson RC. Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. J Comput Assist Tomogr 1997; 21: 229-35. doi: 10.1097/00004728-199703000-00012
  11. Sheafor DH, Frederick MG, Paulson EK, Keogan MT, DeLong DM, Nelson RC. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR Am J Roentgenol 1999; 172: 961-8. doi: 10.2214/ajr.172.4.10587129
  12. Sadigh G, Applegate KE, Baumgarten DA. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic. Acad Radiol 2014; 21: 113-25. doi: 10.1016/j.acra.2013.08.023
  13. García-Garrigós E, Arenas-Jiménez JJ, Sánchez-Payá J. Best Protocol for combined contrast-enhanced thoracic and abdominal CT for lung cancer: a single-institution randomized crossover clinical trial. AJR Am J Roentgenol 2018; 210: 1226-34. doi: 10.2214/ajr.17.19185
  14. Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, Andre F, et al. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4). Ann Oncol 2018; 29: 1634-57. doi: 10.1093/annonc/mdy192
  15. Barter S, Britton P. Breast cancer. In: Nicholson T, editor. Recommendations for cross-sectional imaging in cancer management. Second edition. London: The Royal College of Radiologists; 2014.
  16. Johnson PT, Bello JA, Chatfield MB, Flug JA, Pandharipande PV, Rohatgi S, et al. New ACR choosing wisely recommendations: judicious use of multiphase abdominal CT protocols. J Am Coll Radiol 2019; 16: 56-60. doi: 10.1016/j.jacr.2018.07.026
  17. Siewert B, Sosna J, McNamara A, Raptopoulos V, Kruskal JB. Missed lesions at abdominal oncologic CT: lessons learned from quality assurance. Radiographics 2008; 28: 623-38. doi: 10.1148/rg.283075188
  18. Oliver JH 3rd, Baron RL, Federle MP, Jones BC, Sheng R. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection? Radiology 1997; 205: 709-15. doi: 10.1148/radiology.205.3.9393525
  19. Jee HB, Park MJ, Lee HS, Park MS, Kim MJ, Chung YE. Is non-contrast CT adequate for the evaluation of hepatic metastasis in patients who cannot receive iodinated contrast media? PLoS One 2015; 10: e0134133. doi: 10.1371/journal.pone.0134133
  20. Huh J, Park J, Kim KW, Kim HJ, Lee JS, Lee JH, et al. Optimal phase of dynamic computed tomography for reliable size measurement of metastatic neuroendocrine tumors of the liver: comparison between pre- and post-contrast phases. Korean J Radiol 2018; 19: 1066-76. doi: 10.3348/kjr.2018.19.6.1066
  21. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026
DOI: https://doi.org/10.2478/raon-2021-0029 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 418 - 425
Submitted on: Feb 13, 2021
|
Accepted on: May 1, 2021
|
Published on: Nov 19, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Juan José Arenas-Jiménez, Elena García-Garrigós, Mariana Cecilia Planells-Alduvín, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.